dc.contributor.author | Randall, AD | |
dc.date.accessioned | 2017-02-24T10:08:19Z | |
dc.date.issued | 2016-11-15 | |
dc.description.abstract | The fast emerging technological advances that are enabling biologists to convert stem cells from various sources into an ever-increasing variety of cell types unquestionably will have far-reaching implications for the future of basic bioscientific research. In time, such technologies will also undoubtedly fundamentally change the nature of clinical intervention in multiple disease areas. Indeed stem cell-related therapies are already a widespread feature of the management of lymphoproliferative disorders and leukaemias and interventions in other diseases are increasingly being investigated both in preclinical studies and in formal clinical trials. [...] | en_GB |
dc.identifier.citation | Vol. 594 (22), pp. 6569 - 6572 | en_GB |
dc.identifier.doi | 10.1113/JP273348 | |
dc.identifier.uri | http://hdl.handle.net/10871/26056 | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley / Physiological Society | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/27870124 | en_GB |
dc.rights.embargoreason | Publisher policy | en_GB |
dc.title | Are stem cell-derived neural cells physiologically credible? | en_GB |
dc.type | Article | en_GB |
exeter.place-of-publication | England | en_GB |
dc.description | This is the author accepted manuscript. The final version is available from Wiley via the DOI in this record. | en_GB |
dc.identifier.journal | Journal of Physiology | en_GB |